AspirinFeverQ FeverYellow FeverTyphoid FeverPlatelet Aggregation InhibitorsFever of Unknown OriginAnti-Inflammatory Agents, Non-SteroidalRheumatic FeverRift Valley FeverHemorrhagic Fevers, ViralLassa FeverTiclopidineHemorrhagic Fever, CrimeanThromboxane B2Boutonneuse FeverCyclooxygenase InhibitorsHemorrhagic Fever with Renal SyndromeAfrican Swine Fever VirusPlatelet AggregationRocky Mountain Spotted FeverSalicylatesParatyphoid FeverClassical Swine FeverHemorrhagic Fever Virus, Crimean-CongoPlatelet Function TestsDrug Therapy, CombinationAfrican Swine FeverCoxiella burnetiiSodium SalicylateBlood PlateletsHemorrhagic Fever, AmericanFibrinolytic AgentsHemorrhageAsthma, Aspirin-InducedSalmonella typhiAnticoagulantsIbuprofenHemorrhagic Fever, EbolaWarfarinTablets, Enteric-CoatedCyclooxygenase 1Gastrointestinal HemorrhageDengueProstaglandin-Endoperoxide SynthasesSevere DengueDose-Response Relationship, DrugBleeding TimePlatelet ActivationTreatment OutcomeThromboxanesDouble-Blind MethodAcetaminophenRickettsia InfectionsRisk FactorsPhlebotomus FeverRickettsiaTime FactorsThromboxane A2Prospective StudiesThrombosisCyclooxygenase 2 InhibitorsPyrogensDipyridamoleIndomethacinLassa virusDrug ResistanceLipoxinsEphemeral FeverDrug HypersensitivityRickettsia rickettsiiDisease OutbreaksCyclooxygenase 2Myocardial InfarctionGastric MucosaSulfinpyrazoneProstaglandinsStrokeDengue VirusDinoprostoneIncidenceBorreliaReye SyndromeNaproxenAntipyreticsStomach UlcerDrug Administration ScheduleFollow-Up StudiesTrench Fever